Cell nucleuses were stained with 50g/mL propidium iodide (PI) (MultiSciences Biotech Co,

Cell nucleuses were stained with 50g/mL propidium iodide (PI) (MultiSciences Biotech Co,.Ltd China) at room temperature for 5min. only occurred in HPV16-derived tumors of Rabbit Polyclonal to SGCA mice as early as 30 min post-injection, not in HPV-negative and HPV18-derived tumors. The accumulation of Dylight755-conjugated ZHPV16E7384 in tumor was achieved over a longer time period (24 h). The data here provide strong evidence that E7-specific affibody molecules have great potential utilized for molecular imaging and diagnosis of HPV-induced cancers. Keywords: cervical malignancy, human papillomavirus, E7, affibody molecules, in vivo imaging INTRODUCTION Cervix carcinoma (CxCa) caused by contamination with high-risk human papillomavirus (HR-HPV) remains to be the most fatal gynecologic malignancy worldwide despite global efforts to prevent this disease by early screening, diagnosis and treatment in the past decades [1]. An accurate diagnosis of cervical malignancy, especially the specific detection of tumor metastasis and invasion, is essential for determining treatment of malignancy patients and predicting the clinical outcome. Persistent contamination of HR-HPVs including HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, and 59 has been demonstrated to be the major etiological cause of CxCa [2, 3], with that HPV16 infection alone contributes to over 50% malignancy cases [4]. Thus, HPV-based screening is very important for predicting the incidence of invasive malignancy. Recently, Ronco imaging and malignancy targeted therapy due to their small size and low immunogenicity [18]. Several high affinity affibody molecules targeting many tumor-associated proteins have been generated over the last few years. These proteins include human epidermal growth factor receptor 2 (HER2) [19], epidermal growth factor receptor (EGFR) [20] and insulin-like growth factor type 1 (IGF1R) [21]. In this statement, we describe screening and characterization of four HPV16 E7-binding affibody molecules and their application to molecular imaging in tumor-bearing mice. Four potential affibody molecules (ZHPV16 E7127, ZHPV16E7301, ZHPV16E7384 and ZHPV16E7745) were screened from phage display library by panning, ELISA screening and DNA sequencing. After CRA-026440 confirming the affinity and specificity of these selected affibody molecules in binding to HPV16 E7, affibody ZHPV16E7384 was conjugated with Dylight755 dyes. This Dylight755-conjugated affibody was further accessed for the application to image HPV16-positive tumor in mice. To our knowledge, this is the first time to statement that HPV16 E7-specific affibody is usually a novel probe utilized for imaging and diagnosis of HPV16-positive tumor. RESULTS Selection of HPV16 E7-binding affibody molecules One hundred fifty clones that showed significantly higher conversation with HPV16 E7 were selected for DNA sequencing after four-round panning of bacteriophage display and following an ELISA screening for target-binding activity CRA-026440 (Supplementary Physique S1). Four potential HPV16 E7-binding affibody molecules: ZHPV16E7127, ZHPV16E7301, ZHPV16E7384 and ZHPV16E7745, which showed the highest rating of binding affinity in the ELISA screening were selected for sequence homologous analysis. Results showed that this four molecules had a high homology in framework region of the affibody, but were highly diverse in the helical regions (Physique ?(Figure1).1). Several clones with high binding affinity, such as clone 921, 992, 1037, et al. were discarded because there were one or two mutations in framework region of the affibody. The four affibody genes were subsequently inserted into a pET21a (+) vector to construct four affibody gene expression plasmids. The four CRA-026440 affibody molecules expressed in were purified by Ni-NTA agarose affinity chromatography. The purity of the final products was approximately 95% for these recombinant proteins determined by SDS-PAGE with Coomassie blue staining (Physique ?(Figure22). Open in a separate window Physique 1 Amino acid sequence alignment of wild-type Z domain name and four selected affibody moleculesThree -helices in the wild-type Z domain name are boxed and randomized amino acid residues are offered. Horizontal dots show amino acid identities. Open in a separate window Physique 2 SDS-PAGE of 4 purified HPV16 E7-binding affibodiesProtein bands were visualized with Coomassie Amazing Blue staining. Lane 1, Z wt; lane 2, ZHPV16E7127; lane 3, ZHPV16E7301; lane 4, ZHPV16E7384 and lane 5, ZHPV16E7745; M, marker molecular masses. Biosensor binding analyses of the selected affibody molecules Affinity is the most important house for tumor-targeting imaging agent. Thus, the affinities of 4 affibody molecules and wild type SPA-Z scaffold (Z wt) affibody molecule based on their binding to recombinant HPV16 E7 were firstly analyzed (Physique ?(Figure3).3). All 4 affibody molecules have good binding profiles. The dissociation equilibrium constants (KD) of ZHPV16E7127, ZHPV16E7301, ZHPV16E7384 and ZHPV16E7745 were 4.8210?5, 2.2110?6 mol/L, 2.2010?6 mol/L and 1.8010?6 mol/L mol/L, respectively, which were significantly lower.